The company said its investors in its series A and B rounds, which raised $15m in total, including from Switzerland-based drugs company Novartis' corporate venturing fund, and venture capital firms Vertical Group, Integra Ventures and Westfield Life Sciences Fund.
US-based medical device maker Tepha has raised $5m of a planned $5.15m round from 40 investors.
News provider CityBizList first noticed Tepha’s regulatory filing.
The company said its investors in its series A and B rounds, which raised $15m in total, including from Switzerland-based drugs company Novartis’ corporate venturing fund, and venture capital firms Vertical Group, Integra Ventures and Westfield Life Sciences Fund.
